Komipharm International Co., Ltd. (KOSDAQ: 041960)

Komipharm International Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 18, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	263,602	293,942	446,056	548,450	858,749	969,689
Market Cap Growth	-27.91%	-34.10%	-18.67%	-36.13%	-11.44%	-17.31%
Enterprise Value	285,978	324,970	476,056	565,527	878,631	994,115
Last Close Price	3805.00	4190.00	6350.57	7804.20	12219.61	13854.95
PE Ratio	23.18	-	-	-	-	-
PS Ratio	4.82	6.89	11.21	15.30	23.11	27.32
PB Ratio	4.03	4.90	6.79	7.57	11.00	12.73
P/TBV Ratio	4.45	5.22	7.36	8.26	11.27	13.25
P/OCF Ratio	85.82	-	-	-	34076.71	1019.87
EV/Sales Ratio	5.24	7.62	11.96	15.78	23.64	28.01
EV/EBITDA Ratio	46.99	-	21308.58	-	561.53	-
EV/EBIT Ratio	94.25	-	-	-	-	-
Debt / Equity Ratio	0.62	0.75	0.58	0.46	0.46	0.54
Debt / EBITDA Ratio	7.21	-	1706.78	-	22.80	-
Asset Turnover	0.42	0.37	0.35	0.30	0.30	0.27
Inventory Turnover	2.11	1.93	1.87	1.77	1.83	1.90
Quick Ratio	0.80	0.52	0.53	0.93	0.72	1.05
Current Ratio	1.31	0.96	1.01	1.61	1.14	1.51
Return on Equity (ROE)	19.70%	-9.41%	-10.84%	-7.89%	-5.13%	-26.72%
Return on Assets (ROA)	1.46%	-3.40%	-2.09%	-2.79%	-1.10%	-2.56%
Return on Capital (ROIC)	1.66%	-3.75%	-2.27%	-3.01%	-1.18%	-2.71%
Earnings Yield	4.31%	-1.35%	-1.46%	-0.81%	-0.33%	-2.20%
FCF Yield	0.99%	-1.17%	-0.60%	-0.38%	-0.19%	-0.49%
Buyback Yield / Dilution	2.72%	0.18%	-0.01%	-0.09%	-0.37%	-0.13%
Total Shareholder Return	2.72%	0.18%	-0.01%	-0.09%	-0.37%	-0.13%

Source: S&P Capital IQ. Standard template. Financial Sources.